Position in DERM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,093,294
+$1,172,122 QoQ
Shares Held
295,663
+50.5% QoQ
Ownership
1.05%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#9
of 71 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DERM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Diametric Capital, LP holds $21,852,087 across 7 Drug Manufacturers - Specialty & Generic names. DERM ranks #5 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
105,781 | $8,433,919 | |
| 2 | HROW |
Harrow, Inc.
|
116,908 | $4,965,082 | |
| 3 | ETON |
Eton Pharmaceuticals, Inc.
|
73,101 | $2,646,256 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
26,976 | $2,233,073 | |
| 5 | DERM |
Journey Medical Corp
This page
|
295,663 | $2,093,294 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
7,486 | $1,261,690 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
1,972 | $218,773 |
All Filings in DERM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,093,294 | 295,663 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $921,172 | 196,412 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $398,475 | 51,683 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||